Literature DB >> 16757616

Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil.

Eliane Lages-Silva1, Luis Eduardo Ramírez, André Luiz Pedrosa, Eduardo Crema, Lúcia Maria da Cunha Galvão, Sérgio Danilo Junho Pena, Andrea Mara Macedo, Egler Chiari.   

Abstract

The clinical course of Chagas' disease varies widely among different patients and geographic regions. For reasons that are not completely understood but involve host and parasite factors, some patients never develop the disease while others present cardiac and/or gastrointestinal symptoms. Many studies have been conducted in order to correlate the genetic variability of the parasites with the clinical forms of the disease, but no conclusive data have been obtained. Our research aims at characterizing the genetic profiles of Trypanosoma cruzi isolates recently obtained from 70 chagasic patients who either showed pathological lesions with symptoms of various intensities or were asymptomatic. All patients came from an area where Chagas' disease is endemic in southeast Brazil where vectorial transmission has been controlled and different clinical forms of the disease can be found. The molecular characterization of parasites evaluated the polymorphisms of the 3' region of the 24Salpha rRNA gene and the variability of kinetoplast DNA (kDNA) minicircles of T. cruzi populations by low-stringency single specific primer PCR. Data presented here provide a strong correlation between T. cruzi II and human infection in this region. However, a high degree of variability was observed within T. cruzi II, as demonstrated by intense kDNA polymorphism among all clinical forms and also within each of them, irrespective of the intensity of pathological processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757616      PMCID: PMC1489452          DOI: 10.1128/JCM.02124-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Recommendations from a satellite meeting.

Authors: 
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  [Clinical and radiological aspects of aperistalsis of the esophagus].

Authors:  J de REZENDE; K M LAUAR; A de OLIVEIRA
Journal:  Rev Bras Gastroenterol       Date:  1960 Sep-Dec

3.  Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil.

Authors:  A O Luquetti; M A Miles; A Rassi; J M de Rezende; A A de Souza; M M Póvoa; I Rodrigues
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

4.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease.

Authors:  A M Macedo; S D Pena
Journal:  Parasitol Today       Date:  1998-03

5.  Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil.

Authors:  M A Miles; A Souza; M Povoa; J J Shaw; R Lainson; P J Toye
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

Review 6.  The structure and replication of kinetoplast DNA.

Authors:  T A Shapiro; P T Englund
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

7.  [Hemoculture: sensitive technique in the detection of Trypanosoma cruzi in chagasic patients in the chronic phase of Chagas disease].

Authors:  Z M Luz; M G Coutinho; J R Cançado; A U Krettli
Journal:  Rev Soc Bras Med Trop       Date:  1994 Jul-Sep       Impact factor: 1.581

8.  Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers.

Authors:  S Brisse; J C Dujardin; M Tibayrenc
Journal:  Mol Biochem Parasitol       Date:  2000-11       Impact factor: 1.759

Review 9.  Parasite persistence in the aetiology of Chagas disease.

Authors:  R L Tarleton
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

10.  Changes in Trypanosoma cruzi kinetoplast DNA minicircles induced by environmental conditions and subcloning.

Authors:  A M Alves; D F De Almeida; W M von Krüger
Journal:  J Eukaryot Microbiol       Date:  1994 Jul-Aug       Impact factor: 3.346

View more
  20 in total

Review 1.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

2.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Cytotaxonomy of Trypanosoma cruzi (Chagas, 1909): Differentiation of T. cruzi I (TcI) and T. cruzi II (TcII) Genotypes Using Cytogenetic Markers.

Authors:  Ana Beatriz Bortolozo de Oliveira; Aline Rimoldi Ribeiro; Fernanda Fernandez Madeira; Natália Regina Cesaretto; João Aristeu da Rosa; Maria Tercília Vilela de Azeredo-Oliveira; Kaio Cesar Chaboli Alevi
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

Review 4.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

5.  Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients.

Authors:  Daniella Alchaar D'Avila; Andréa Mara Macedo; Helder Magno Silva Valadares; Eliane Dias Gontijo; Ana Maria de Castro; Carlos Renato Machado; Egler Chiari; Lúcia Maria Cunha Galvão
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

6.  Homogeneity of Trypanosoma cruzi I, II, and III populations and the overlap of wild and domestic transmission cycles by Triatoma brasiliensis in northeastern Brazil.

Authors:  Antonia Cláudia Jácome da Câmara; Eliane Lages-Silva; George Harisson Felinto Sampaio; Daniella Alchaar D'Ávila; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2013-01-31       Impact factor: 2.289

7.  Co-infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes.

Authors:  Luísa M D Magalhães; Lívia S A Passos; Egler Chiari; Lúcia M C Galvão; Carolina C Koh; Marina L Rodrigues-Alves; Rodolfo C Giunchetti; Kenneth Gollob; Walderez O Dutra
Journal:  Parasite Immunol       Date:  2019-09-30       Impact factor: 2.280

8.  Intra-Discrete Typing Unit TcV Genetic Variability of Trypanosoma cruzi in Chronic Chagas' Disease Bolivian Immigrant Patients in Barcelona, Spain.

Authors:  Maykon Tavares de Oliveira; Elena Sulleiro; Maria Cláudia da Silva; Aroa Silgado; Marta de Lana; João Santana da Silva; Israel Molina; J Antônio Marin-Neto
Journal:  Front Cardiovasc Med       Date:  2021-05-20

9.  KDNA genetic signatures obtained by LSSP-PCR analysis of Leishmania (Leishmania) infantum isolated from the new and the old world.

Authors:  Janaína Sousa Campos Alvarenga; Carla Maia Ligeiro; Célia Maria Ferreira Gontijo; Sofia Cortes; Lenea Campino; Annamaria Ravara Vago; Maria Norma Melo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  LSSP-PCR of Trypanosoma cruzi: how the single primer sequence affects the kDNA signature.

Authors:  Marcela Segatto; Claudiney Melquíades Rodrigues; Carlos Renato Machado; Glória Regina Franco; Sérgio Danilo Junho Pena; Andréa Mara Macedo
Journal:  BMC Res Notes       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.